Wuxi Biologics (Cayman) Inc.
Summary
Wuxi Biologics (Cayman) Inc. is registered in the Cayman Islands. Its legal form is company limited by shares (Ltd). Wuxi Biologics (Cayman) Inc. is the ultimate parent of a group of 1 subsidiary in 2 countries, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by legal entities that are not subject to accounting consolidation. The LEI was first issued on 29 Jul 2017 and the record was last updated on 3 Aug 2023. It has lapsed: renewal was due by 27 Jul 2018. GLEIF's ISIN mapping lists 2 ISINs for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 27 Jul 2018 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
Company details
| Legal form | company limited by shares (Ltd) |
|---|---|
| Jurisdiction | Cayman Islands |
| Registered address | PO Box 309, Ugland House, KY1-1104 George Town, Cayman Islands |
| Headquarters address | 12th Floor, 10004 New York, United States |
| Category | company or other legal entity |
| Status | active |
| LEI | 5493001TD2TH6VDTJU11 |
| LEI status | lapsed |
| LEI first issued | 29 Jul 2017 |
| LEI record last updated | 3 Aug 2023 |
| Next LEI renewal | 27 Jul 2018 |
| Corroboration of the LEI record | supplied by the entity only |
Group membership
Parent not reported to GLEIF
- Direct parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
- Ultimate parent: the entity is controlled by legal entities that are not subject to accounting consolidation.
ISINs mapped to this LEI (2)
KYG970081173 · US98260N1081
2 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.